The expression of EGFR was alongside the expression of other prominent breast cancer biomarkers such as the androgen receptor and Ki67 protein (the cellular marker for cell proliferation), thus suggesting EGFR is another therapeutic target for breast cancer treatment [69]. This evidence concerns the gene MKI67 and breast carcinoma.